Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

PURPOSE: Myelofibrosis (MF) may serve as a poor prognostic factor in myelodysplastic syndromes (MDS). This study explored the impact of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on the outcome of MDS patients with MF. PATIENTS AND METHODS: Three hundred and sixteen MDS patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xiangzong, Xuan, Li, Fan, Zhiping, Zhang, Yu, Zhao, Ke, Zhou, Ya, Xu, Jun, Liu, Qifa, Dai, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364708/
https://www.ncbi.nlm.nih.gov/pubmed/34391477
http://dx.doi.org/10.1186/s40164-021-00238-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364708/
https://www.ncbi.nlm.nih.gov/pubmed/34391477
http://dx.doi.org/10.1186/s40164-021-00238-x

Ejemplares similares